NCT05539287View on ClinicalTrials.gov

Clinical Study Evaluating the Safety of Lactobacillus Probiotic in Children With Drug Resistant Epilepsy

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 25, 2022

Primary Completion Date

August 5, 2024

Study Completion Date

February 1, 2025

Conditions
Drug Resistant Epilepsy
Interventions
DRUG

Lactobacillus-Based Capsule

25 patients will receive Lactobacillus species 5 billion colonies forming unit (CFU) 2 capsules daily together with their standard antiepileptic drug for 6 months.

Trial Locations (1)

Unknown

Amira, Tanta

All Listed Sponsors
lead

Tanta University

OTHER